Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,459 public trials 541 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Active, Not Recruiting

Trial in AML Secondary to MPNs Patients, Unfit for Intensive Chemotherapy, Investigating a Treatment Combination Including Decitabine and Venetoclax

NCT04763928

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Ematologia A.O. SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Ematologia AOU delle Marche Ancona, Italy
  • Ematologia AOU Policlinico Bari Bari, Italy
  • Ematologia ASST Papa Giovanni XXIII Bergamo, Italy
View all 33 locations
View Trial Details
Active, Not Recruiting

Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy

NCT03603795

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • CHU ANGERS - Maladies du sang Angers, France
  • CH de la Côte Basque - Hématologie Bayonne, France
  • CHU Estaing Clermont-Ferrand, France
  • CHU Grenoble - Hématologie Clinique Grenoble, France
View all 15 locations
View Trial Details
Active, Not Recruiting

Dexamethasone Added to Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML)

NCT03609060

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • CHU ANGERS - Maladies du sang Angers, France
  • Ch Avignon Avignon, France
  • CH de la Côte Basque - Hématologie Bayonne, France
  • CHRU JEAN MINJOZ - Hématologie Besançon, France
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy

NCT03839771

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • AU-Adelaide-FLINDERS Adelaide, Australia
  • AU-Adelaide-RAH Adelaide, Australia
  • AU-Brisbane-PAH Brisbane, Australia
  • AU-Camperdown-RPA Camperdown, Australia
View all 181 locations
View Trial Details
Active, Not Recruiting

Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia

NCT03789981

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • AO Spedali Civili di Brescia Brescia, BS, Italy
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Meldola, FC, Italy
  • IRCCS Casa sollievo sofferenza San Giovanni Rotondo, FOGGIA, Italy
  • IRCCS AOU S. Martino Genova Genova, GE, Italy
View all 14 locations
View Trial Details
Active, Not Recruiting

Venetoclax + Cytarabine Versus Idarubicin + Cytarabine : Efficacity Assessment as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission

NCT04968015

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • ANGERS - CHU - Maladies du sang Angers, France
  • ANNECY - Centre Hospitalier Annecy-Genevois Annecy, France
  • AVIGNON - Centre Hospitalier Avignon, France
  • BAYONNE - CH de la Côte Basque - Hématologie Bayonne, France
View all 26 locations
View Trial Details

Related conditions